The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More

Pharma’s Almanac’s David Alvaro, Ph.D., examines the many potential applications for digital twin technology in the pharmaceutical industry, from accelerating drug discovery and development to optimizing manufacturing processes and clinical trials and potentially facilitating the development of personalized medicines.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: